12 Best Upside Stocks to Buy Now
On November 14, Alli McCartney, UBS Private Wealth Management managing director, joined 'Squawk Box' on CNBC to discuss the latest market trends and what to make of the recent volatility.
Biocryst Pharmaceuticals Inc (BCRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 12,169,000 | $92,362,710 | +160% | 1.41% |
| 2. | Kynam Capital Derrick Tang | 9,390,270 | $71,272,149 | +11% | 5.31% |
| 3. | Alkeon Capital Management Panayotis Takis Sparaggis | 5,464,021 | $41,471,919 | -5% | 0.06% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 5,225,986 | $39,665,234 | +23% | 0.03% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 4,240,712 | $32,187,004 | +1% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.36 | 7,861 | $49,995.96 | 44,951 | 2024-05-30 | Filing | |
| $6.40 | 2,500 | $16,000.00 | 2,500 | 2024-05-24 | Filing | |
| $6.38 | 5,000 | $31,900.00 | 86,818 | 2024-05-20 | Filing | |
| $6.25 | 15,000 | $93,750.00 | 66,997 | 2024-05-20 | Filing | |
| $5.57 | 36,300 | $202,191.00 | 266,744 | 2024-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.14 | 9,600 | $68,544.00 | 30,642 | 2025-11-13 | Filing | |
| $8.51 | 70,000 | $595,868.00 | 65,352 | 2025-08-13 | Filing | |
| $7.54 | 7,000 | $52,780.00 | 86,638 | 2024-12-13 | Filing | |
| $6.32 | 8,600 | $54,352.00 | 27,831 | 2024-06-24 | Filing | |
| $6.00 | 4,689 | $28,134.00 | 27,742 | 2024-06-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 21,790,881 | $165,392,786 | 0% | |
| 2. | 21,245,876 | $161,256,203 | 0% | |
| 3. | 9,807,438 | $74,438,454 | 0% | |
| 4. | 5,967,737 | $45,295,124 | 0.01% | |
| 5. | 5,202,959 | $39,490,462 | 0% |
News See All
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2025 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2025 Earnings Call Transcript November 3, 2025BioCryst Pharmaceuticals, Inc. misses on earnings expectations.
BioCryst Sells European ORLADEYO Business for $250M Upfront to Focus on US Market
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best stocks to buy under $20.
10 Best Stocks to Buy Under $20
On September 16, Ali Dibadj, Janus Henderson Investors CEO, joined 'Squawk Box' on CNBC to discuss the latest market trends and suggest that small and mid-cap stocks have enormous potential to deliver...
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 Revenue Soars 49%, Hits Record $163.4 Million on ORLADEYO Surge
BioCryst Pharmaceuticals, Inc.
11 Best Pharma Stocks to Invest in for the Long Term
According to a recent White House announcement, President Trump wrote letters to 17 major pharmaceutical companies outlining the actions they could take to bring the prices of prescription pharmaceuticals...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to the BioCryst Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
13 Best Healthcare Stocks to Buy Under $10
On June 27, Tiffany McGhee, CEO of Pivotal Advisors, appeared on CNBC to talk about the best course of action for investors amid current market dynamics.
BioCryst Pharmaceuticals Sells European ORLADEYO Business for Up to $264M
BioCryst Pharmaceutical Inc. (NASDAQ:BCRX) is one of the best high short interest stocks with huge upside potential.
10 Best High Short Interest Stocks With Huge Upside Potential
Abby Yoder, JPMorgan Private Bank's chief equity strategist, joined CNBC's 'Closing Bell' on July 2 to discuss the market's momentum as stocks began the second half of the year. Yoder confirmed her continued...